Navigation Links
CMPI to Host Hill Briefing on Follow-On Biologic Drugs for Media and Congressional Staff with Reps. Eshoo and Rogers
Date:7/8/2009

WASHINGTON, July 8 /PRNewswire-USNewswire/ -- Next Wednesday, July 15th, on Capitol Hill, the Center for Medicine in the Public Interest will host a briefing followed by a question-and-answer session for media and Congressional Staff entitled: "A Follow-On Biologics Legislation Update; Congressional Leaders and Medical Experts Discuss Patient Safety." The event will be co-hosted by two high-ranking members of the House Energy and Commerce Committee, Congresswoman Anna Eshoo (D-CA) and Congressman Mike Rogers (R-MI). The Representatives are lead sponsors of bipartisan legislation to modernize the regulatory pathway for Food and Drug Association approval of follow-on biologics.

Representative Eshoo's legislation: H.R. 1548, the Pathway for Biosimilars Act ensures that new standards for testing will make certain that follow-on biologic drugs are both safe and effective. The bill currently has 108 cosponsors and has the broadest bipartisan support of any legislation designed to regulate follow-on biologics.

"CMPI applauds Representatives Eshoo's and Rogers' commitment to ensuring patient safety is the top-priority for follow-on biologics legislation," said Robert Goldberg of CMPI. "The next few weeks are going to be a pivotal time in Congress as health care takes top billing in the House and the Senate. It is critical that advocates for safe and effective follow-on biologics do all they can to support Representative Eshoo's legislation. Representatives Eshoo's and Rogers' dedication to ensuring FDA takes the appropriate steps to ensure the safety of patients could mean the difference between health and illness for millions of Americans."

Also speaking at the event will be former Congressman Mike Ferguson; Dr. Geno Merli, Senior Vice President & Chief Medical Officer, Thomas Jefferson University, and Director, Jefferson Center for Vascular Diseases; and John F. Crowley, President and Chief Executive Officer of Amicus Therapeutics. All three will help highlight the importance of balancing cost reduction and the well-being of patients in the follow-on biologics debate, bringing their unique experiences and perspectives directly to Hill staffers.

WHO: Representative Anna Eshoo (D-CA), Representative Mike Rogers (R-MI), Leading Medical Experts

WHAT: Briefing for media and Congressional staff

WHEN: Next Wednesday, July 15th, 12-1 p.m.

WHERE: Cannon Caucus Room, Cannon House Office Building 3rd Floor, Washington, D.C.

WHY: A Follow-On Biologics Legislation Update; Congressional Leaders and Medical Experts Discuss Patient Safety

Those interested in attending this event can RSVP via email to Meryl Reichbach at mreichbach@cmpi.org or by calling her at 212-417-9169.

About CMPI

The Center for Medicine in the Public Interest, a non-profit public policy group dedicated to research-based free market reforms for the health care industry.


'/>"/>
SOURCE Center for Medicine in the Public Interest
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Briefing on a new Web resource to address global drinking water crisis
2. Audio Replay: Catholic Charities USAs Briefing on the Inextricable Link Between a Veto of SCHIP and Poverty in America
3. Nephrologists summarize new renal research during public policy news briefing at Renal Week
4. Press briefings to address longevity, mobility, brain fitness at GSAs San Francisco meeting
5. National physician organization supports Capps-Rogers Bill at todays congressional briefing
6. Exelixis Announces December 10 Webcast of Its Analyst and Investor Briefing in Conjunction With The American Society of Hematology 48th Annual Meeting
7. Reminder: Exelixis Announces December 10 Webcast of Its Analyst and Investor Briefing in Conjunction with The American Society Of Hematology 48th Annual Meeting
8. Capitol Hill Briefing Features Technologies That Could Transform the Lives of Seniors
9. Congressional Briefing on Pre-Diabetes and Vision Health
10. U.S. Health Disparities Forum to Hold Media Briefing
11. Nationwide Telephone News Briefing for U.S. Health Disparities Forum
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/22/2017)... ... February 22, 2017 , ... The Waismann Method® ... of individuals who have recently fallen victim to America’s opioid epidemic. Now, opiate dependent ... California, where they are free from the shame, stigma, and harmful labeling ...
(Date:2/22/2017)... ... February 22, 2017 , ... ... understand each Medicare Advantage member’s risk, identify any gaps-in-coding, as well as ... helps transform the HCC Risk Adjustment process from a typical fragmented process ...
(Date:2/22/2017)... ... February 22, 2017 , ... ... serum, “NANOCALM 300” Microemulsified Hemp Extract. This premier nanoemulsified CBD product utilizes ... into the bloodstream. Far outpacing the absorption speed of all other ...
(Date:2/22/2017)... ... February 22, 2017 , ... Becker’s Spine Review, the leading ... Michigan neurosurgeon Jay Jagannathan, M.D., as a “Spine Surgeon to Know.” http://www.beckersspine.com/spine-leaders/item/35348- ... in Michigan performing minimally invasive back surgery that often results in less post-operative ...
(Date:2/22/2017)... ... February 22, 2017 , ... The SeniorCare Investor will ... Forecast —on Thursday, February 23, 2017, at 1:00 PM ET. A recording of the ... of the Interactive Webinar Series. , If you want to find out what really ...
Breaking Medicine News(10 mins):
(Date:2/22/2017)... , February 22, 2017 According to a ... Forceps, Trocar, SIMS, CUSCO), Application (Laparoscopy, Colposcopy, Hysteroscopy, D&C, Ablation, Biopsy), ... to 2021", published by MarketsandMarkets, the global market is expected to ... 2016, at a CAGR of 7.1% during the forecast period. ... ...
(Date:2/22/2017)... Feb 22, 2017 Research and Markets ... Development Pipeline Review, 2016" report to their offering. ... Dermatological ... worldwide, and approximately one-third of the US population suffers from ... the majority of the dermatology market has remained saturated with ...
(Date:2/22/2017)... , February 22, 2017 A research ... North America and the continuously changing landscape of ... in 2016 in the North America , a ... to increase to $21.6 billion by the year 2021 representing a ... the United States and Canada ...
Breaking Medicine Technology: